头颈部癌的化疗.pptVIP

RR TPF TPF-4 TPF-5 PFL n=23 n=30 n=40 CR(%) 14(61) 19(63) 17(40) PR(%) 9(39) 9(30) 22(53) CR+PR(%) 23(100) 28(93) 40(93) CR at primary site(%) 86 72 69 Overall survival 78(3-yr) 83(2-yr) 52(5-yr) Disease free survival(%) 78(3-yr) 53(2-yr)